The Zhitong Finance App learned that on Friday, Moderna (MRNA.US) rose more than 5% to $254.36. According to the news, Moderna announced results for the third quarter of 2026. According to financial reports, the company's total revenue was US$1,313 million, up 29% year on year, far higher than market expectations of about US$885 million; net profit of US$162 million, reversing losses compared to a net loss of US$200 million in the same period last year; and diluted earnings per share of US$0.38, which was significantly better than the market's expected loss of 1.25 US dollars per share.

Zhitongcaijing · 1d ago
The Zhitong Finance App learned that on Friday, Moderna (MRNA.US) rose more than 5% to $254.36. According to the news, Moderna announced results for the third quarter of 2026. According to financial reports, the company's total revenue was US$1,313 million, up 29% year on year, far higher than market expectations of about US$885 million; net profit of US$162 million, reversing losses compared to a net loss of US$200 million in the same period last year; and diluted earnings per share of US$0.38, which was significantly better than the market's expected loss of 1.25 US dollars per share.